Central adiposity as a major risk factor of ovarian cancer

Anticancer Research

Volumn 29, Issue 12, 2009, Pages 5229-5234

  Delort, Laetitia ^a,b   Kwiatkowski, Fabrice ^a   Chalabi, Nassera ^a,b   Satih, Samir ^a,b   Bignon, Yves Jean ^a,b,c   Bernard Gallon, Dominique J ^a,b  

^a CENTRE JEAN PERRIN   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Central adiposity; Ovarian cancer; Risk factors

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; OBESITY; OVARY CANCER; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; WAIST HIP RATIO;

ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OBESITY; OVARIAN NEOPLASMS; RISK FACTORS; WAIST-HIP RATIO;

EID: 75149188824     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Trétarre B, Remontet L, Menegoz F et al: Ovarian cancer: incidence and mortality in France. J Gynecol Obstet Biol Reprod (Paris) 34: 154-161, 2005.
2. Risch HA: Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90: 1774-1786, 1998.
3. Fathalla MF: Incessant ovulation-a factor in ovarian neoplasia? Lancet 2: 163, 1971.
4. Lew EA and Garfinkel L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32: 563-576, 1979.
5. Kwiatkowski F, Girard M, Hacène K and Berlie J: SEM: a suitable statistical software adaptated for research in oncology. Bull Cancer 87: 715-721, 2000.
6. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ and Thun MJ: Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11: 822-828, 2002.
7. Schouten LJ, Goldbohm RA and van den Brandt PA: Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157: 424-433, 2003.
8. Hirose K, Tajima K, Hamajima N et al: Comparative case-referent study of risk factors among hormone-related female cancers in Japan. Jpn J Cancer Res 90: 255-261, 1999.
9. Riman T, Dickman PW, Nilsson S et al: Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. Gynecol Oncol 83: 575-585, 2001.
10. Purdie DM, Bain CJ, Webb PM, Whiteman DC, Pirozzo S and Green AC: Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control 12: 855-863, 2001.
11. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003.
12. Farrow DC, Weiss NS, Lyon JL and Daling JR: Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol 129: 1300-1304, 1989.
13. Lubin F, Chetrit A, Freedman LS et al: Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157: 113-120, 2003.
14. Lahmann PH, Cust AE, Friedenreich CM et al: Anthropometric measures and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition. Int J Cancer, 2009.
15. Engeland A, Tretli S and Bjorge T: Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95: 1244-1248, 2003.
16. Dal Maso L, Franceschi S, Negri E et al Body size indices at different ages and epithelial ovarian cancer risk. Eur J Cancer 38: 1769-1774, 2002.
17. Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE and Hankinson SE: Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100: 288-296, 2002.
18. Kuper H, Cramer DW and Titus-Ernstoff L: Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 13: 455-463, 2002.
19. Wolk A, Gridley G, Svensson M et al: A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12: 13-21, 2001.
20. Moller H, Mellemgaard A, Lindvig K and Olsen JH: Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A: 344-350, 1994.
21. Slattery ML, Schuman KL, West DW, French TK and Robison LM: Nutrient intake and ovarian cancer. Am J Epidemiol 130: 497-502, 1989.
22. Anderson JP, Ross JA and Folsom AR: Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study. Cancer 100: 1515-1521, 2004.
23. Lukanova A, Toniolo P, Lundin E et al: Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer 99: 603-608, 2002.
24. Beehler GP, Sekhon M, Baker JA et al: Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 136: 2881-2886, 2006.
25. Schouten LJ, Rivera C, Hunter DJ et al: Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 17: 902-912, 2008.
26. Leitzmann MF, Koebnick C, Danforth KN et al: Body mass index and risk of ovarian cancer. Cancer 115: 812-822, 2009.
27. Greer JB, Modugno F, Ness RB and Allen GO: Anthropometry and the risk of epithelial ovarian cancer. Cancer 106: 2247-2257, 2006.
28. Baer HJ, Hankinson SE and Tworoger SS: Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health Studies. Br J Cancer 99: 1916-1922, 2008.
29. Mink PJ, Folsom AR, Sellers TA and Kushi LH: Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women. Epidemiology 7: 38-45, 1996.
30. Rodriguez GC, Walmer DK, Cline M et al: Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Investig 5: 271-276, 1998.
31. Riman T, Dickman PW, Nilsson S et al: Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 94: 497-504, 2002.
32. Lacey JV Jr, Mink PJ, Lubin JH et al: Menopausal hormone replacement therapy and risk of ovarian cancer. Jama 288: 334-341, 2002.
33. Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 14: 1132-1143, 1991.
34. Weiderpass E, Ye W, Vainio H, Kaaks R and Adami HO: Diabetes mellitus and ovarian cancer (Sweden). Cancer Causes Control 13: 759-764, 2002.
35. Lukanova A and Kaaks R: Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14: 98-107, 2005.
36. La Vecchia C: Oral contraceptives and ovarian cancer: an update, 1998-2004. Eur J Cancer Prev 15: 117-124, 2006.
37. Greer JB, Modugno F, Allen GO and Ness RB: Short-term oral contraceptive use and the risk of epithelial ovarian cancer. Am J Epidemiol 162: 66-72, 2005.
38. Ness RB, Grisso JA, Klapper J et al: Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions. Am J Epidemiol 152: 233-241, 2000.
39. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK and Henderson BE: "Incessant ovulation" and ovarian cancer. Lancet 2: 170-173, 1979.
40. Killick S, Eyong E and Elstein M: Ovarian follicular development in oral contraceptive cycles. Fertil Steril 48: 409-413, 1987.
41. Bertone ER, Newcomb PA, Willett WC, Stampfer MJ and Egan KM: Recreational physical activity and ovarian cancer in a population-based case-control study. Int J Cancer 99: 431-436, 2002.
42. Weiderpass E, Margolis KL, Sandin S et al: Prospective study of physical activity in different periods of life and the risk of ovarian cancer. Int J Cancer 118: 3153-3160, 2006.
43. Hannan LM, Leitzmann MF, Lacey JV Jr et al: Physical activity and risk of ovarian cancer: a prospective cohort study in the United States. Cancer Epidemiol Biomarkers Prev 13: 765-770, 2004.